Propolis and its flavonoid compounds cause cytotoxicity on human urinary bladder transitional cell carcinoma in primary culture

Periodicum Biologorum

Volumn 111, Issue 1, 2009, Pages 113-121

  Oršolić, Nada ^a   Štajcar, Damir ^b   Bašić, Ivan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Varazdin General Hospital   (Croatia)

Author keywords

Cytotoxicity; Flavonoids; Human urinary bladder cancer; Primary culture; Propolis

Indexed keywords

AURANTIIN; BCG VACCINE; CAFFEIC ACID; CHRYSIN; DIHYDROFLAVONOL; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL; FLAVONOL DERIVATIVE; POLYPHENOL DERIVATIVE; PROPOLIS; QUERCETIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER GRADING; CANCER INHIBITION; CANCER PREVENTION; CANCER RECURRENCE; CANCER STAGING; CARCINOMA CELL; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; TRANSURETHRAL RESECTION;

EID: 64149092490     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. JEMAL A, TIWARI R C, MURRAY T, GHAFOOR A, SAMUELS A, WARD E, FEUER E J, THUN M J 2004 American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 54(1): 8-29
2. HUEPER W C 1969 Cancers in rats and mice fed with commercial fish feeds. Z Krebsforsch. 73(2): 141-8. German.
3. HICKS R M, JAMES C, WEBBE G 1980 Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon. Br J Cancer 42(5): 730-55
4. RAGHAVAN D 2003 Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder. Urol Oncol 21(6): 468-74.
5. RAGHAVAN D. 2003 Molecular targeting and pharmacogenomics in the management of advanced bladder cancer. Cancer 97 (8 Suppl): 2083-9.
6. RAGHAVAN D 2003 Progress in the chemotherapy of metastatic cancer of the urinary tract. Cancer 97 (8 Suppl): 2050-5.
7. GREEN D F, ROBINSON M R, GLASHAN R, NEWLING D, DALESIO O, SMITH P H 1984 Does intravesical chemotherapy prevent invasive bladder cancer? J Urol 131(1): 33-5
8. SYLVESTER R J 2006 The use of intravesical chemotherapy and possibilities for improving its efficacy. Eur Urol 50(2): 233
9. KURTH K H, DENIS L, TEN KATE F F J W, SYLVESTER RDE PAUW M, BOUFFIOUX C, DEBRUYNE F M J, PAVONE-MACALUSO M, OOSTERLINCK W 1992 Prognostic factors in superficial bladder tumors. In: Solway M S, Paulson D F (eds), Problems in Urology, JB Lippincott, Philadelphia, 1992, p 471-483
10. ORŠOLIĆ N, BAŠIĆ I 2007 Cancer chemoprevention by propolis and its polyphenolic compounds in experimental animals. Recent Progress in Medicinal Plants 17: 55-113
11. ORŠOLIĆ N, BAŠIĆ I 2003 Immunomodulation by water-soluble derivative of propolis (WSDP), a factor of antitumor reactivity. J Ethnopharmacol 84: 265-273.
12. POPOVA M, BANKOVA V, BUTOVSKA D, PETKOV V, NIKOLOVA-DAMYANOVA B, SABATINI A G, MARCAZZAN G L, BOGDANOV S 2004 Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Analysis 15: 235-240
13. CHANG C C, YANG M H, WEN H M, CHERN J C 2002 Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal 10: 178-182
14. CHEN C N, WENG M S, WU C-L, LIN J K 2004 Comparison of radical scavenging activity, cytotoxic effects and apoptosis induction in human melanoma cells by Taiwanese propolis from different sources. eCAM 1: 175-185
15. KOSALEC I, BAKMAZ M, PEPELJNJAK S, VLADIMIR KNEŽEVIć S 2004 Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharm 54: 65-72
16. SATO D, MATSUSHIMA M 2003 Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int J Urol 10(3): 160-6
17. YAO R, DAVIDSON D D, LOPEZ-BELTRAN A, MACLENNAN G T, MONTIRONI R, CHENG L 2007 The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 22(9): 1025-32.
18. ORŠOLIĆ N, ŠVER L, TERZIĆ S, TADIĆ Z, BAŠIĆ I 2003 Inhibitory effect of water-soluble derivative of propolis (WSDP) and its polyphenolic compounds on tumor growth and metastasing ability: A possible mode of antitumor action. Nutr Cancer 47: 156-163
19. ORŠOLIĆ N, BAŠIĆ I 2005 Water soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. J Ethnopharmacol 102: 37-45
20. ORŠOLIĆ N, BAŠIĆ I 2005 Antitumor, hematostimulative and radioprotective action of water - soluble derivative of propolis (WSDP). Biomed Pharmacother 59: 561-570
21. SU S J, YEH T M, LEI H Y, CHOW N H 2000 The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6(1): 230-6
22. IKEMOTO S, SUGIMURA K, YOSHIDA N, YASUMOTO R, WADA S, YAMAMOTO K, KISHIMOTO T 2000 Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55(6): 951-5
23. YANG M, TANAKA T, HIROSE Y, DEGUCHI T, MORI H, KAWADA Y 1997 Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer 73(5): 719-24
24. TANAKA T, MAKITA H, OHNISHI M, HIROSE Y, WANG A, MORI H, SATOH K, HARA A, OGAWA H 1994 Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 54(17): 4653-9
25. CHIGNOLA R, FORONI R, FRANCESCHI A, PASTI M, CANDIANI C, ANSELMI C, FRACASSO G, TRIDENTE G, COLOMBATTI M 1995 Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin. Br J Cancer 72(3): 607-14
26. CSOKAY B, PRAJDA N, WEBER G, OLAH E 1997 Molecular mechanisms in the antiproliferative action of quercetin. Life Sci 60(24): 2157-63
27. WILLIAMS R J, SPENCER J P, RICE-EVANS C 2004 Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36(7): 838-49
28. AVILA M A, CANSADO J, HARTER K W, VELASCO J A, NOTARIO V 1996 Quercetin as a modulator of the cellular neoplastic phenotype. Effects on the expression of mutated H-ras and p53 in rodent and human cells. Adv Exp Med Biol 401: 101-10
29. SU S J, YEH T M, CHUANG W J, HO C L, CHANG K L, CHENG H L, LIU H S, CHENG H L, HSU P Y, CHOW N H 2005 The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 69(2): 307-18
30. MOUSA S S, MOUSA S S, MOUSA S A 2005 Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52(1): 59-65
31. YANG S H, LIN J K, CHEN W S, CHIU J H 2003 Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J Surg Res 113(1): 133-8
32. LIU J J, HUANG T S, CHENG W F, CHIU J H 2003 Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation. Int J Cancer 106(4): 559-65
33. HAYASHI A, GILLEN A C, LOTT JR 2000 Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice. Altern Med Rev 5(6): 546-52
34. GALATI G, TENG S, MORIDANI M Y, CHAN T S, O'BRIEN P J 2000 Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol Drug Interact 17: 311-349
35. KANG S S, KIM J S, SON K H, KIM H P, CHANG H W 2000 Isolation of COX-2 inhibitors from Alpinia officinarum. Kor J Pharmacogen 31: 57-62
36. SHIMOI K, SAKA N, KAJI K, NOZAWA R, KINAE N 2000 Metabolic fate of luteolin and its functional activity at focal site. Biofactors 12(1-4): 181-6
37. RASO G M, MELI R, DI CARLO G, PACILIO M, DI CARLO R 2001 Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 68(8): 921-31
38. FOSSLIEN E 2000 Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30(1): 3-21
39. HOWE L R, SUBBARAMAIAH K, BROWN A M, DANNENBERG A J 2001 Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 8(2): 97-114
40. YOSHIMURA R, MATSUYAMA M, TSUCHIDA K, KAWAHITO Y, SANO H, NAKATANI T 2003 Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 170(5): 1994-9
41. MOHSENI H, ZASLAU S, MCFADDEN D, RIGGS D R, JACKSON B J, KANDZARI S 2004 COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro. J Surg Res 119(2): 138-42
42. FOSSLIEN E 2000 Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 37(5): 431-502
43. TURINI M E, DUBOIS R N 2002 Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53: 35-57
44. TURINI M E, DUBOIS R N 2002 Primary prevention: phytoprevention and chemoprevention of colorectal cancer. Hematol Oncol Clin North Am 16(4): 811-40
45. LEAHY K M, KOKI A T, MASFERRER J L 2000 Role of cyclooxygenases in angiogenesis. Curr Med Chem 7(11): 1163-70
46. MASFERRER J L, LEAHY K M, KOKI A T, ZWEIFEL B S, SETTLE S L, WOERNER B M, EDWARDS D A, FLICKINGER A G, MOORE R J, SEIBERT K 2000 Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60(5): 1306-11
47. HIDA T, KOZAKI K, MURAMATSU H, MASUDA A, SHIMIZU S, MITSUDOMI T, SUGIURA T, OGAWA M, TAKAHASHI T, TAKAHASHI 2000 Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 5: 2006-2011
48. CHANG W S, LEE Y J, LU F J, CHIANG H C 1993 Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 13(6A): 2165-70
49. CHAN W S, WEN P C, CHIANG H C 1995 Structure-activity relationship of caffeic acid analogues on xanthine oxidase. Anticancer Res 15: 703-707
50. MARKOVITS J, LINASSIER C, FOSSE P, COUPRIE J, PIERRE J, JACQUEMIN-SABLON A, SAUCIER J M, LE PECQ J B, LARSEN A K 1989 Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49(18): 5111-5117
51. MIDDLETON E JR, KANDASWAMI C, THEOHARIDES T C 2000 The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52(4): 673-751
52. KEMBERLING J K, HAMPTON J A, KECK R W, GOMEZ M A, SELMAN S H 2003 Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol 170(3): 773-6
53. CHEN J J, YE Z Q, KOO M W 2004 Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 93(7): 1082-6
54. OKAMURA K, ONO Y, KINUKAWA T, MATSUURA O, YAMADA S, ANDO T, FUKATSU T, OHNO Y, OHSHIMA S, NAGOYA UNIVERSITY UROLOGICAL ONCOLOGY GROUP 2002 Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma. Cancer 94(9): 2363-8
55. SOLSONA E, IBORRA I, RICOS J V, MONROS J L, CASANOVA J, DUMONT R 1999 Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up. J Urol 161(4): 1120-3
56. ORŠOLIĆ N, TERZIĆ S, MIHALJEVIĆ Ž, ŠVER L, BAŠIĆ I 2005 Effect of local administration of propolis and its polyphenolic compounds on the tumour formation and growth. Biol Pharm Bull 28: 1928-1933
57. ORŠOLIĆ N, ŠVER L, TERZIĆ S, BAŠIĆ I 2005 Peroral application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and thieir influence on immunological and antitumor activity. Vet Res Comun 29: 575-93
58. ORŠOLIĆ N, TERZIĆ S, ŠVER L, BAŠIĆ I 2005 Polyphenolic compounds from propolis modulate immune responses and increase host resistance to tumor cells. Food Agric Immunol 16: 165-179